IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.

作者: Toshiya Fujii , Hideki Kitaura , Keisuke Kimura , Zaki Weli Hakami , Teruko Takano-Yamamoto

DOI: 10.1016/J.BONE.2012.06.024

关键词: Tumor necrosis factor alphaRANKLOsteoclastImmunologyMolecular biologyInterleukin 4CytokineIn vivoChemistryStromal cellT cell

摘要: It has been reported that osteoclastogenesis is induced by tumor necrosis factor (TNF)-α. Interleukin (IL)-4 the most important cytokine involved in humoral immunity. However, no studies have investigated effect of IL-4 on TNF-α-mediated osteoclast formation vivo. In this study, we TNF-α was administered with and without into supracalvariae mice. The number osteoclasts levels mRNA for cathepsin K tartrate-resistant acid phosphate, both markers, mice were lower than those alone. level phosphatase form 5b (TRACP5b) as a marker bone resorption also lower. We showed inhibited precursors vitro. Expression receptor activator NF-κB ligand (RANKL) TNF-α-activated stromal cells inhibited. Furthermore, whether had effects Using whose chimeric presence TNF receptors, TNF-α-responsive cells, TNF-α-induced RANKL expression This event dependent p38 inhibition Additionally, T cell-depleted summary, conclude inhibiting directly vivo via cell-independent mechanism.

参考文章(37)
Young-Yun Kong, Hiroki Yoshida, Ildiko Sarosi, Hong-Lin Tan, Emma Timms, Casey Capparelli, Sean Morony, Antonio J. Oliveira-dos-Santos, Gwyneth Van, Annick Itie, Wilson Khoo, Andrew Wakeham, Colin R. Dunstan, David L. Lacey, Tak W. Mak, William J. Boyle, Josef M. Penninger, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature. ,vol. 397, pp. 315- 323 ,(1999) , 10.1038/16852
D E Griswold, B Votta, J C Lee, J L Adams, A M Badger, J N Bradbeer, Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. Journal of Pharmacology and Experimental Therapeutics. ,vol. 279, pp. 1453- 1461 ,(1996)
S. L. Teitelbaum, Bone Resorption by Osteoclasts Science. ,vol. 289, pp. 1504- 1508 ,(2000) , 10.1126/SCIENCE.289.5484.1504
Hideki Kitaura, Ping Zhou, Hyun-Ju Kim, Deborah V Novack, F Patrick Ross, Steven L Teitelbaum, M-CSF mediates TNF-induced inflammatory osteolysis Journal of Clinical Investigation. ,vol. 115, pp. 3418- 3427 ,(2005) , 10.1172/JCI26132
Steven L. Teitelbaum, F. Patrick Ross, Hideki Kitaura, Shi Wei, Ping Zhou, IL-1 mediates TNF-induced osteoclastogenesis Journal of Clinical Investigation. ,vol. 115, pp. 282- 290 ,(2005) , 10.1172/JCI23394
Masataka Nishikawa, Akira Myoui, Tetsuya Tomita, Koichiro Takahi, Akihide Nampei, Hideki Yoshikawa, Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis & Rheumatism. ,vol. 48, pp. 2670- 2681 ,(2003) , 10.1002/ART.11227
Yukiko Morita, Hideki Kitaura, Masako Yoshimatsu, Yuji Fujimura, Haruka Kohara, Toshiko Eguchi, Noriaki Yoshida, IL-18 Inhibits TNF-α-Induced Osteoclastogenesis Possibly via a T Cell-Independent Mechanism in Synergy with IL-12 In Vivo Calcified Tissue International. ,vol. 86, pp. 242- 248 ,(2010) , 10.1007/S00223-010-9335-6
Shi Wei, Michael W.-H. Wang, Steven L. Teitelbaum, F. Patrick Ross, Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling Journal of Biological Chemistry. ,vol. 277, pp. 6622- 6630 ,(2002) , 10.1074/JBC.M104957200
G. A. Rodan, Therapeutic Approaches to Bone Diseases Science. ,vol. 289, pp. 1508- 1514 ,(2000) , 10.1126/SCIENCE.289.5484.1508
Hideki Kitaura, Mutsuhito Tatamiya, Noriko Nagata, Yuji Fujimura, Toshiko Eguchi, Noriaki Yoshida, Koji Nakayama, IL-18 induces apoptosis of adherent bone marrow cells in TNF-α mediated osteoclast formation in synergy with IL-12 Immunology Letters. ,vol. 107, pp. 22- 31 ,(2006) , 10.1016/J.IMLET.2006.06.005